The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma.
Br J Pharmacol
; 173(7): 1236-47, 2016 Apr.
Article
in En
| MEDLINE
| ID: mdl-26989986
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asthma
/
Protein-Tyrosine Kinases
/
Airway Remodeling
/
Dasatinib
/
Lung
Limits:
Animals
Language:
En
Journal:
Br J Pharmacol
Year:
2016
Document type:
Article
Affiliation country:
Country of publication: